Vir Biotechnology logo
Vir Biotechnology VIR
$ 6.95 3.12%

Quarterly report 2024-Q3
added 11-04-2024

report update icon

Vir Biotechnology Income Statement 2011-2024 | VIR

Annual Income Statement Vir Biotechnology

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

Market Cap

1.59 B 3.04 B 5.44 B 3.19 B 714 M - - - - - - - -

Shares

134 M 133 M 130 M 119 M 30.3 M - - - - - - - -

Historical Prices

11.9 22.9 41.9 26.8 12.6 - - - - - - - -

Net Income

-615 M 516 M 529 M -299 M -175 M -116 M -69.9 M - - - - - -

Revenue

86.2 M 1.62 B 1.1 B 76.4 M 8.09 M 10.7 M 2.71 M - - - - - -

Cost of Revenue

2.76 M 146 M 65.9 M - - - - - - - - - -

Gross Profit

- - - - - - - - - - - - -

Operating Income

-684 M 833 M 421 M -297 M -178 M -119 M -81.5 M - - - - - -

Interest Expense

-8.99 M 4.26 M -9.44 M -4.47 M -5.06 M -212 K 83 K - - - - - -

EBITDA

-665 M 839 M 426 M -293 M -173 M -116 M -81.1 M - - - - - -

Operating Expenses

- - - - 186 M 129 M - - - - - - -

General and Administrative Expenses

178 M 162 M 161 M 70.9 M 37.6 M 29.1 M 21.7 M - - - - - -

All numbers in USD currency

Quarterly Income Statement Vir Biotechnology

2024-Q3 2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

Shares

137 M 136 M 135 M 135 M 134 M 134 M 134 M 133 M 133 M 132 M 132 M 131 M 131 M 130 M 128 M 127 M 126 M 115 M 108 M 108 M 10.5 M 9.33 M 9 M 8.86 M 8.04 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Net Income

-214 M -138 M -65.3 M - -163 M -195 M -141 M - 175 M -76.5 M 519 M - 110 M 61.8 M -169 M -106 M -84.6 M -31.2 M -77.2 M -63.8 M -48.3 M -33.9 M -28.7 M -26.4 M -33.5 M -24.4 M -31.6 M - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Revenue

2.38 M 3.08 M 56.4 M - 2.64 M 3.8 M 63 M - 375 M -40.6 M 1.23 B - 104 M 177 M 1.98 M 1.73 M 1.93 M 67 M 5.72 M 980 K 1.4 M 2.05 M 3.66 M 3.13 M 2.88 M 2.22 M 2.43 M - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Cost of Revenue

50 K 52 K 59 K - 38 K 22 K 1.91 M - 22.3 M 27.9 M 90.1 M - 7.84 M 1.14 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Gross Profit

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Operating Income

-231 M -159 M -80.1 M - -187 M -215 M -143 M - 195 M -225 M 1.01 B - -53.4 M 61 M -159 M - -87.6 M -29.1 M -71.9 M - -47.7 M -35.8 M -30.8 M - -34.3 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Interest Expense

-893 K -535 K -287 K - 882 K -367 K -8.02 M - 27 M 691 K 2.73 M - 64 K 752 K -10.2 M - 2.62 M -2.9 M -7.07 M - -2.66 M -447 K -145 K - 178 K - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

EBITDA

-228 M -154 M -75.6 M - -182 M -211 M -138 M - 197 M -224 M 1.02 B - -52 M 62.3 M -157 M - -86.5 M -28 M -70.9 M - -46.8 M -35 M -30.1 M - -33.9 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Operating Expenses

- - - - - - - - - - - - 157 M 116 M 161 M 110 M 89.5 M 96 M 77.6 M 64.7 M 49.1 M 37.8 M 34.4 M 29.9 M 37.2 M 27.2 M 35 M - - - - - - - - - - - - - - - - - - - - - - - - - - - -

General and Administrative Expenses

25.7 M 30.3 M 36.3 M - 40.9 M 45.5 M 46.8 M - 43.2 M 41.6 M 38.3 M - 50.5 M 28.8 M 25.7 M - 18.9 M 16.4 M 12.6 M - 9.22 M 8.01 M 8.56 M - 7.39 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

All numbers in USD currency